ArticleNature communications2025
3D bioprinting of plant and animal cell-based hybrid food.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Oxygen Supply of Islets of Langerhans by Photosynthetically Active Microalgae in Bioprinted Co-Cultures Maintains Their Function in a Hypoxic Environment.Advanced healthcare materials · 2026Article
- 3D biofabricated in vitro models as new approach methodologies for animal alternatives.npj biomedical innovations · 2026Review
- Recent strategies in synthetic food production for sustainable food security: applications and challenges.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular agriculture is an emerging field that leverages stem cell biology, biotechnology, and tissue engineering to produce meat and other agricultural products through cell culture techniques. One of the most promising methods within this domain is three-dimensional (3D) bioprinting, which allows for precise layering of cells to form sophisticated structures. In this study, we introduce fully automated chaotic bioprinting with a custom-built extrusion setup taking advantage of an integrated Kenics static mixer printhead to create plant and animal cell-based hybrid noodles. These bioprinted hybrid noodles are made of approximately 30-40% unicellular plant cells (Chlamydomonas or Chlorella microalgae) and 60-70% muscle cells (C2C12 or chicken myoblasts). We further 3D-bioprinted aesthetically appealing hybrid food products of various shapes and sizes, where their textures, nutritional contents, and cooking behaviors are evaluated. This proof-of-concept study demonstrates that 3D bioprinting can reliably produce a distinct category of plant- and animal cell-based hybrid foods and highlights opportunities to create complex culinary designs and explore diverse nutritional profiles with precision and efficiency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.